Evidence map›Paper›PMID 28616703›Full record

ArticleInternational orthopaedics2017

Preparation of a biphase composite scaffold and its application in tissue engineering for femoral osteochondral defects in rabbits.

Shi-Qiang Ruan, Ling Yan, Jiang Deng, Wen-Liang Huang, Dian-Ming Jiang

Abstract read
PubMed Publisher
In one paragraph

Article in International orthopaedics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Animal Models of Osteochondral Defect for Testing Biomaterials.Biochemistry research international · 2020
    Review
  14. [Research progress on osteochondral tissue engineering].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2019
    Review
  15. Article
  16. [Preparation andZhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2018
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Shi-Qiang RuanDepartment of Orthopaedics Surgery, the First Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China, 400016.
Ling YanDepartment of Orthopaedics Surgery, the First People's Hospital of Zunyi City, Zunyi, People's Republic of China, 563003.
Jiang DengDepartment of Orthopaedics Surgery, the First People's Hospital of Zunyi City, Zunyi, People's Republic of China, 563003.
Wen-Liang HuangDepartment of Orthopaedics Surgery, the First People's Hospital of Zunyi City, Zunyi, People's Republic of China, 563003.
Dian-Ming JiangDepartment of Orthopaedics Surgery, the First Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China, 400016. jdm571026@vip.163.com.
First People’s Hospital of Zunyi · CNChongqing Medical University · CNFirst Affiliated Hospital of Chongqing Medical University · CN

Funding

the National Natural Science Foundation of China 81660367the Science and technology plan projects in Guizhou province [2016] 1420
6 · The paper itself

Abstract

purposeThree-dimensional bioactive scaffolds are useful tools for stem cell implant in tissue-engineering. For chondral and subchondral repair, the chondroinductive and osteoinductive property of a scaffold is a major challenge. The scaffolds that aim to osteogenic differentiation have been well studied. However, cartilage cells can hardly be induced for osteogenesis, and monophase scaffolds cannot ideally repair both cartilage and subchondral defects at the same time.

methodsWe developed a novel biphase composite scaffold and observe its application osteochondral defects. We combined the advantages of silk-fibroin/chitosan (SF/CS) scaffold in chondrogenic differentiation and the silk-fibroin/chitosan/nano-hydroxyapatite (SF/CS/nHA) scaffold in osteogenic differentiation and bone regeneration, and synthesized a SF/CS-SF/CS/nHA scaffold, which contained both the chondrocytic phase (SF/CS) and the osteoblastic phase (SF/CS/nHA).

resultsThe biphase scaffold exhibited a porosity ratio around 90% and a water absorption ratio about 822%. A similar degradation property to traditional monophase scaffolds was observed. Bone mesenchymal stem cells (BMSCs) showed a good proliferation on this scaffold. Expression of two types of collagen was inducable for BMSCs on the scaffold. Neoformative extracellular matrix integrated with the scaffold was observed by the scanning electron microscope. When implanted in the lesion site in the rabbit femur with cartilage injury, mixing and filling function were exerted by the cell-scaffold constructs (CSCs). Micro-CT scanning revealed both chondral and subchondral layers were repaired. Moreover, type I and II collagens were both expressed in the implanted CSCs.

conclusionsChondral and subchondral repair can be achieved using the biphase scaffold implant that permits both chondrogenesis and osteogenesis from BMSCs. This approach has the potential to be clinically used for tissue engineering implantation.

Indexed as

Tissue ScaffoldsAnimalsBlotting, WesternBone RegenerationCartilageCell DifferentiationCells, CulturedChitosanChondrocytesChondrogenesisCollagenFemurFibroinsFluorescent Antibody TechniqueMesenchymal Stem CellsOsteogenesisChitosanCollagenFibroins3D scaffold; tissue engineeringBone mesenchymal stem cellChondrogenesisOsteogenesis

Identifiers

PMID28616703
OpenAlexW2626016663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.